Drug Profile
Clonazepam intranasal
Alternative Names: JZP-8Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Jazz Pharmaceuticals
- Developer Jazz Pharmaceuticals plc
- Class Antiepileptic drugs; Antipsychotics; Anxiolytics; Benzodiazepines; Benzodiazepinones
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Epilepsy
Most Recent Events
- 25 Jun 2015 No recent reports of development identified - Phase-II for Epilepsy in Finland and USA (Intranasal)
- 18 Jan 2012 Azur Pharma has merged with Jazz Pharmaceuticals Inc to form Jazz Pharmaceuticals plc
- 10 Mar 2011 Jazz Pharmaceuticals is no longer actively seeking a licensing partner for clonazepam intranasal